1887
Volume 2022, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: The size of a thyroid nodule and certain sonographic features, such as marked hypoechogenicity, microcalcifications, taller-than-wide shape, microlobulated, or irregular margins, indicate the greater malignancy risk. The frequency of the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category among cytology reports from thyroid fine-needle aspirations ranges from 0.8% to 28%, whereas the risk of malignancy of these nodules varies from 6% to 97%. This retrospective analysis investigated whether the preoperative ultrasonographic location of Bethesda 3 thyroid nodules is a predictive risk factor for differentiated thyroid cancer (DTC).

Methods: A total of 387 patients who underwent total thyroidectomy for a nodule with AUS/FLUS cytology and diagnosed with a DTC at five tertiary referral centers between 2010 and 2020 were retrospectively analyzed. The location of the thyroid nodule with AUS/FLUS cytology was categorized into two groups: one group was composed of the isthmus, upper lobe, middle lobe, and lower lobe, whereas the latter consisted of right lobe, left lobe, and isthmus.

Results: DTC was diagnosed in 40.6% (n = 157) of the operated nodules. Multiple logistic regression analysis has revealed that hypoechogenicity of the nodule (odds ratio [OR] = 2.929,  < 0.001) was the only independent predictive factor for the malignancy of the nodules with AUS/FLUS, whereas the location of the nodule, age, and sex were not significantly independent risk factors. Multifocality and contralateral benign nodules were independent predictive factors for multicentricity (OR = 3.5,  = 0.002; OR = 5.5,  = 0.001, respectively).

Conclusion: As the first study investigating the association between a Bethesda 3 nodule location and the risk of malignancy by evaluating postoperative cytology reports, the results showed that nodule location with AUS/FLUS on fine-needle aspiration biopsy was not a predictive risk factor for the diagnosis of DTC.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.51
2022-11-15
2022-12-07
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/4/qmj.2022.51.html?itemId=/content/journals/10.5339/qmj.2022.51&mimeType=html&fmt=ahah

References

  1. Cancer stat facts: Thyroid Cancer: http://seer.cancer.gov/statfacts/html/thyro.html; Stand: 14.04.2022..
  2. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: The EU-TIRADS. Eur Thyroid J 2017; 6: 225–2371.
    [Google Scholar]
  3. Zhang F, Oluwo OCastillo FBGangula PCastillo MFarag F et al. Thyroid nodule location on ultrasonography as a predictor of malignancy [abstract]. Endocr Pract 2019; 25:(2): 131–137. doi:10.4158/EP-2018-0361.
    [Google Scholar]
  4. Cibas ES, Ali SZ. The 2017 Bethesda System for reporting thyroid cytopathology. Thyroid 2017; 27: 1341–1346. doi:10.1089/thy.2017.0500.
    [Google Scholar]
  5. Kholová I, Ludvíková M. Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: An indispensable Bethesda 2010 diagnostic category or waste garbage? Acta Cytol 2014; 58: 319–329.
    [Google Scholar]
  6. Geramizadeh B, Bos-Hagh SMaleki Z. Cytomorphologic, imaging, molecular findings, and outcome in thyroid follicular lesion of undetermined significance/atypical cell of undetermined significance (AUS/FLUS): A mini-review. Acta Cytol 2019; 63: 1–9.
    [Google Scholar]
  7. Huhtamella R, Kholová I. Thyroid Bethesda category AUS/FLUS in our microscopes: Three-year-experience and cyto-histological correlation. Cancers (Basel) 2019; 11. doi:10.3390/cancers11111670.
    [Google Scholar]
  8. Pastorello R, Valerio ELobo AMaia ASaieg M. Do thyroid nodules that arise in the isthmus have a higher risk of malignancy? Cancer Cytopathol 2020; 128: (8): 520–522. doi:10.1002/cncy.22260.
    [Google Scholar]
  9. Jasim S, Baranski TJTeefey SAMiddleton WD. Investigating the effect of thyroid nodule location on the risk of thyroid cancer. Thyroid 2020; 30: 401–407. doi:10.1089/thy.2019.0478.
    [Google Scholar]
  10. Xavier-Júnior JCC, Abrantkoski Borges FPizzello Zogheib RJCamilo-Júnior DJ. Bethesda System categories of fine needle aspiration cytology are not associated with thyroid nodule location: A single institution experience. Acta Cytol 2021; 65:(1):22–26. doi:10.1159/000510175.
    [Google Scholar]
  11. Ramundo V, Lamartina LFalcone RCiotti LLomonaco CBiffoni M et al. Is thyroid nodule location associated with malignancy risk? Ultrasonography 2019; 38: 231–235. doi:10.14366/usg.18050.
    [Google Scholar]
  12. Ron E, Modan BPreston DAlfandary EStovall MBoice, JD Jr. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 1989; 120:(3):516–531. doi:10.2307/3577801.
    [Google Scholar]
  13. Li P, Wu MWang JSui YLiu SShi D. NAC selectively inhibit cancer telomerase activity: A higher redox homeostasis threshold exists in cancer cells. Redox Biol 2016; 8: 91–97. doi:10.1016/j.redox.2015.12.001.
    [Google Scholar]
  14. Coquia SF, Chu LCHamper UM. The role of sonography in thyroid cancer. Radiol Clin North Am 2014; 52: 1283–1294.
    [Google Scholar]
  15. Lee YC, Eun YGSohn YMRhee SYHong IKChon S et al.. Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features. World J Surg 2015; 39: 1736–1741. doi:10.1007/s00268-015-3024-6.
    [Google Scholar]
  16. Pitt SC, Sippel RSChen H. Contralateral papillary thyroid cancer: Does size matter? Am J Surg 2009; 197: 342–347. doi:10.1016/j.amjsurg.2008.09.011.
    [Google Scholar]
  17. Jo P, Kesruek HNietert MSahlmann COGaedcke JGhadimi M et al.. Incidence and predictive factors for bilaterality in patients with papillary thyroid carcinoma. Zentralblatt fur Chir - Zeitschrift fur Allg Visz und Gefasschirurgie 2018; 143: 361–366. doi:10.1055/a-0651-0878.
    [Google Scholar]
  18. Chen X, Zhong ZSong MYuan JHuang ZDu J et al.. Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: A retrospective study. Gland Surg 2020; 9: 872–878. doi:10.21037/gs-19-157.
    [Google Scholar]
  19. Yang LM, Li QZhao BWLyu JGXu HSXu LL et al.. [Prediction of occult carcinoma in contralateral nodules based on the ultrasonic features of unilateral papillary thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2017; 52:(4):259–262. doi:10.3760/cma.j.issn.1673-0860.2017.04.004.
    [Google Scholar]
  20. Lv T, Zhu CDi Z. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre. Clin Endocrinol (Oxf) 2018; 88: 279–284. doi:10.1111/cen.13506.
    [Google Scholar]
  21. Koo BS, Lim HSLim YCYoon YKim YMPark YH et al.. Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma. Ann Surg Oncol 2010; 17: 1101–1105. doi:10.1245/s10434-009-0906-6.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.51
Loading
/content/journals/10.5339/qmj.2022.51
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error